Research Topics
| Stephen TyringSummaryAffiliation: The University of Texas Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Once, twice, or three times daily famciclovir compared with aciclovir for the oral treatment of herpes zoster in immunocompetent adults: a randomized, multicenter, double-blind clinical trialStephen D Shafran
Division of Infectious Diseases, Department of Medicine, 2E4 16 Walter C Mackenzie Health Sciences Centre, University of Alberta Hospital, 8440 112 Street, Edmonton, Alta, Canada T6G 2B7
J Clin Virol 29:248-53. 2004....
Valomaciclovir versus valacyclovir for the treatment of acute herpes zoster in immunocompetent adults: a randomized, double-blind, active-controlled trialStephen K Tyring
Departments of Dermatology, Microbiology and Molecular Genetics, and Internal Medicine, University of Texas Health Science Center, Houston, TX, USA
J Med Virol 84:1224-32. 2012..Nausea, headache, and vomiting were the most common adverse events. Based on these results, additional studies are warranted to define further EPB-348's potential as an effective and safe therapy for acute herpes zoster...
Single-day therapy: an expert opinion on a recent development for the episodic treatment of recurrent genital herpesStephen Tyring
Department of Dermatology, Microbiology and Molecular Genetics and Internal Medicine, University of Texas Health Science Center, 2060 Space Park Drive, Suite 200, Houston, TX 77058, USA
Arch Gynecol Obstet 275:1-3. 2007..Because single-day treatment is more convenient than traditional therapies, it may lead to improved patient compliance and better overall management of recurrent genital herpes outbreaks...
Management of herpes zoster and postherpetic neuralgiaStephen K Tyring
Department of Dermatology, The University of Texas, Houston, Texas, USA
J Am Acad Dermatol 57:S136-42. 2007..There is a need for more effective agents to treat herpes zoster and postherpetic neuralgia...
Single-day therapy for recurrent genital herpesStephen Tyring
Department of Dermatology, University of Texas Health Science Center, Houston, Texas 77058, USA
Am J Clin Dermatol 7:209-11. 2006..In addition, the convenience of single-day treatment may lead to greater patient adherence and improved overall management of recurrent herpes outbreaks...
Long-term safety and efficacy of 50 mg of etanercept twice weekly in patients with psoriasisStephen Tyring
Department of Dermatology, The University of Texas Health Center at Houston, 6655 Travis, Suite 120, Houston, TX 77030, and Evanston Northwest Healthcare, Skokie, IL, USA
Arch Dermatol 143:719-26. 2007..To evaluate the safety and efficacy of long-term treatment of psoriasis with etanercept, 50 mg twice weekly...
Double-blind study comparing 2 dosages of valacyclovir hydrochloride for the treatment of uncomplicated herpes zoster in immunocompromised patients 18 years of age and olderAnita Arora
Department of Dermatology, University of Texas Houston School of Medicine, Houston, TX 77030, USA
J Infect Dis 197:1289-95. 2008..Participants in both arms of the study demonstrated similar median times to full crusting of the rash (8 days), and both dosages were safe and effective therapies for reduction of ZAP and ZAAS in the immunocompromised patient population...
Early treatment of cold sores with topical ME-609 decreases the frequency of ulcerative lesions: a randomized, double-blind, placebo-controlled, patient-initiated clinical trialChristopher M Hull
Department of Dermatology, School of Medicine, University of Utah, Salt Lake City, Utah 84132 2409, USA
J Am Acad Dermatol 64:696.e1-11. 2011..ME-609 (Xerese, Xerclear) is a combination of 5% acyclovir and 1% hydrocortisone developed for the topical treatment of HSL...
Open-label study of valacyclovir 1.5 g twice daily for the treatment of uncomplicated herpes zoster in immunocompetent patients 18 years of age or olderVandana K Madkan
Department of Dermatology, University of Texas School of Medicine, Center for Clinical Studies, Houston, TX 77030, USA
J Cutan Med Surg 11:89-98. 2007..Valacyclovir HCl, the L-valyl ester of acyclovir, is an antiviral drug that is used to accelerate the resolution of the herpes zoster rash and associated pain and reduce the duration of postherpetic neuralgia...
Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trialStephen Tyring
Department of Dermatology, University of Texas Health Science Center at Houston, Houston, TX, USA
Lancet 367:29-35. 2006..INTERPRETATION: Etanercept treatment might relieve fatigue and symptoms of depression associated with this chronic disease...
ASP2151 for the treatment of genital herpes: a randomized, double-blind, placebo- and valacyclovir-controlled, dose-finding studyStephen Tyring
Department of Dermatology, University of Texas Health Science Center, Houston, TX, USA
J Infect Dis 205:1100-10. 2012..Current therapies for genital herpes have only partial efficacy. Helicase-primase inhibitors are novel, potent inhibitors of herpes simplex virus replication...
Single-day treatment for orolabial and genital herpes: a brief review of pathogenesis and pharmacologySapna Modi
Baylor College of Medicine Houston, TX, USA
Ther Clin Risk Manag 4:409-17. 2008..Lastly, the reduced number of pills necessary for single versus multiple day therapy decreases the overall cost of treatment per episode, an important factor in modern-day healthcare...
Mucocutaneous manifestations of Epstein-Barr virus infectionNatalia Mendoza
Center for Clinical Studies, Houston, Texas, USA
Am J Clin Dermatol 9:295-305. 2008..Since the immune system is critical in preventing the progression of EBV disease, the immunologic status of the patient plays a crucial role in the subsequent development of pathologies...
Single-dose famciclovir for the treatment of herpes labialisChristopher Hull
Department of Dermatology, University of Utah School of Medicine, Salt Lake City, UT 84132 2405, USA
Curr Med Res Opin 22:1699-702. 2006..The pharmacokinetic/pharmacodynamic profile of famciclovir suggests that it could be utilized for episodic treatment for immunocompetent individuals as well...
Incidence of postherpetic neuralgia after combination treatment with gabapentin and valacyclovir in patients with acute herpes zoster: open-label studyWhitney Lapolla
Center for Clinical Studies, 451 N Texas Ave, Webster, TX 77598, USA
Arch Dermatol 147:901-7. 2011..To evaluate the efficacy of treatment with gabapentin plus valacyclovir hydrochloride for the prevention of postherpetic neuralgia in patients with acute herpes zoster...
Filariasis: diagnosis and treatmentNatalia Mendoza
Universidad El Bosque, Bogota, Colombia
Dermatol Ther 22:475-90. 2009..However, continued research on new drugs and vaccinations will be needed to control and reduce the microfilarial levels in the human population...
Shingles vaccineC Beau Willison
Center for Clinical Studies, 451 North Texas Avenue, Webster, Texas 77598, USA
Expert Opin Biol Ther 10:631-8. 2010..Inc.) is effective in preventing shingles in individuals 60 years of age and older and recommended by the Center for Disease Control's (CDC) Advisory Committee for Immunization Practices (ACIP)...
Safety and efficacy of vaccinesBrenda L Bartlett
Center for Clinical Studies, University of Texas Health Science Center, Houston, Texas, USA
Dermatol Ther 22:97-103. 2009..In the future, it is anticipated that safe and effective vaccines will be developed against a number of other viral and bacterial infections as well as fungal and protozoan diseases...
Vaccine immunologyBrenda L Bartlett
Center for Clinical Studies, University of Texas Health Sciences Health Science Center, Houston, Texas, USA
Dermatol Ther 22:104-9. 2009..These strains must have constant antigenic properties. A number of vaccine types exist, both traditional and innovative, and are described herein...
Famciclovir treatment options for patients with frequent outbreaks of recurrent genital herpes: the RELIEF trialBrenda L Bartlett
University of Texas Health Science Center, Houston, TX 77058, United States
J Clin Virol 43:190-5. 2008..Recurrent genital HSV outbreaks are common among those suffering from the disease. Antiviral medications taken as suppressive therapy can reduce the frequency of these recurrences and reduce viral shedding occurring in between recurrences...
Emerging drugs for complicated skin and skin-structure infectionsNatalia Mendoza
Center for Clinical Studies, 6655 Travis Suite 120, Houston, TX 77030, USA
Expert Opin Emerg Drugs 15:509-20. 2010..The need for new antibiotics is evident and the effort to decrease antibiotic resistance is a world priority...
Acquired epidermodysplasia verruciformisHeather D Rogers
Department of Dermatology, Columbia University Medical Center, New York, New York, USA
J Am Acad Dermatol 60:315-20. 2009....
Epidermodysplasia verruciformis and susceptibility to HPVTejas Patel
Center for Clinical Studies, University of Texas Health Science Center, Houston, TX, USA
Dis Markers 29:199-206. 2010....
Valacyclovir for the treatment of genital herpesJulie S Brantley
The University of Texas Medical Branch, Department of Dermatology, 301 University Boulevard, Galveston, TX 77555 0783, USA
Expert Rev Anti Infect Ther 4:367-76. 2006..The less frequent dosing regimen makes it an attractive option in the treatment of genital herpes and other viral infections, and may contribute to increased patient adherence to therapy...
Recurrent genital herpes treatments and their impact on quality of lifeMathijs H Brentjens
Departments of Dermatology, Microbiology/Immunology and Internal Medicine, University of Texas Medical Branch-Galveston, Houston, Texas 77058, USA
Pharmacoeconomics 21:853-63. 2003..Newer therapeutic modalities, including the topical immune response modifier resiquimod and herpes vaccines, may eventually be shown to further decrease the psychological morbidity of recurrent genital herpes...
A calcipotriene/betamethasone dipropionate two-compound scalp formulation in the treatment of scalp psoriasis in Hispanic/Latino and Black/African American patients: results of the randomized, 8-week, double-blind phase of a clinical trialStephen Tyring
Center for Clinical Studies, Department of Dermatology, University of Texas Health Science Center, Houston, TX, USA
Int J Dermatol 49:1328-33. 2010..0%) and the vehicle group (7.9%). The two-compound scalp formulation is safe and effective in the treatment of scalp psoriasis over 8 weeks in Hispanic/Latino and Black/African American patients...
Antiviral agents: Non-antiretroviral [correction of Nonantiviral] drugsTricia J Brown
Department of Dermatology, Microbiology/Immunology and Internal Medicine, University of Texas Medical Branch, Galveston 77555, USA
J Am Acad Dermatol 47:581-99. 2002..This review of antiviral agents discusses the treatments available for viral infections such as herpes simplex virus, varicella zoster virus, cytomegalovirus, human papillomavirus, chronic viral hepatitis, and others...
Managing herpes zoster in immunocompromised patientsAmmar M Ahmed
Baylor College of Medicine, Houston, TX, USA
Herpes 14:32-6. 2007..Appropriate analgesic therapy should be combined with early antiviral treatment to reduce the incidence and severity of acute zoster pain and post-herpetic neuralgia...
Valacyclovir in the treatment of herpes simplex, herpes zoster, and other viral infectionsJashin J Wu
Department of Internal Medicine, Baylor College of Medicine, Houston, Texas, USA
J Cutan Med Surg 7:372-81. 2003..CONCLUSION: Valacyclovir is safe and effective in the therapy of patients with herpes simplex and herpes zoster and may be useful in other viral infections...
Cutaneous phaeohyphomycosis caused by Paraconiothyrium cyclothyrioidesRachel A Gordon
Center for Clinical Studies, Houston, Texas, USA
J Clin Microbiol 50:3795-8. 2012..cyclothyrioides. Treatment with posaconazole led to complete resolution of the lesions. P. cyclothyrioides should be considered an opportunistic human pathogen in immunocompromised patients...
Ileostomy-associated chronic papillomatous dermatitis showing nevus sebaceous-like hyperplasia, HPV 16 infection, and lymphedema: a case report and literature review of ostomy-associated reactive epidermal hyperplasiasPreethi Raghu
Divisions of Dermatology and Dermatopathology, Albany Medical College, Albany, NY 12208, USA
Am J Dermatopathol 34:e97-102. 2012..We postulate that localized lymphedema secondary to scarring coupled with chronic epidermal irritation and inflammation allowed for latent HPV infection to manifest as CPD with NS-like cutaneous hyperplasia...
Epidermodysplasia verruciformis and human papilloma virusAron Gewirtzman
Center for Clinical Studies, Houston, TX 77030, USA
Curr Opin Infect Dis 21:141-6. 2008..We focus on recent findings in genetics, highlight multiple viewpoints regarding the role of epidermodysplasia verruciformis-human papillomavirus in nonmelanoma skin cancer and other diseases, and discuss treatment strategies...
Infection and panniculitisL Katie Morrison
Department of Dermatology, University of Texas Health Sciences Center, Houston, Texas, USA
Dermatol Ther 23:328-40. 2010..Diagnosis and treatment are also discussed...
Viremia in acute herpes zosterAnita K Satyaprakash
Center for Clinical Studies, University of Texas Health Science Center, Houston, Texas, USA
J Infect Dis 200:26-32. 2009..A phase 2 trial was conducted to evaluate the efficacy of a topical antiviral, sorivudine, as an adjuvant to valacyclovir for the treatment of acute herpes zoster...
Resiquimod: a new immune response modifier with potential as a vaccine adjuvant for Th1 immune responsesJashin J Wu
Department of Dermatology, University of California, Irvine, Irvine, CA, USA
Antiviral Res 64:79-83. 2004..Resiquimod shows promise for other viral infections and as a vaccine adjuvant...
Vaccines for viral diseases with dermatologic manifestationsMathijs H Brentjens
University of Texas Medical Branch-Galveston, Department of Dermatology, Galveston, TX, USA
Dermatol Clin 21:349-69. 2003..Ongoing research shows promise in prophylactic and therapeutic vaccination for viral infections with cutaneous manifestations. Further studies are necessary before vaccines for HSV, HPV, and HIV become commercially available...
Vaccines under study: non-HIV vaccinesKelly Conner
The University of Texas Medical School, Houston, Texas 77030, USA
Dermatol Ther 22:168-85. 2009..This article focuses on vaccines that have yet to be approved for licensure...
Current and potential uses of imiquimodYuchi C Chang
Department of Intemal Medicine, University of Texas Health Science Center at Houston, Houston, TX 77030, USA
South Med J 98:914-20. 2005..Common skin conditions that may be eradicated with imiquimod are emphasized...
Retapamulin: an antibacterial with a novel mode of action in an age of emerging resistance to Staphylococcus aureusJeffrey M Weinberg
Clinical Research Center, Department of Dermatology, St Luke s Roosevelt Hospital Center, NewYork, NY 10025, USA
J Drugs Dermatol 9:1198-204. 2010..aureus and Streptococcus pyogenes and may play an important role in limiting the development of resistance against systemic agents...
The management of herpes simplex virus infectionsKimberly A Yeung-Yue
Department of Dermatology, University of Texas Medical Branch-Galveston, Galveston, Texas, USA
Curr Opin Infect Dis 15:115-22. 2002..However, immunologic advances in the treatment and prevention of herpes simplex infections are promising and continue to be studied...
A review of antibiotics in dermatologyDaniel A Carrasco
Department of Dermatology, University of Texas Medical Branch-Galveston, Galveston, Texas, USA
J Cutan Med Surg 6:128-50. 2002..These antibiotics are used to treat a variety of organisms...
Treatment of anogenital warts with imiquimod 5% cream followed by surgical excision of residual lesionsDaniel Carrasco
Department of Dermatology, University of Texas Medical Branch at Galveston, Texas, USA
J Am Acad Dermatol 47:S212-6. 2002..Therefore, treatment with imiquimod followed by excision of residual lesions may provide long-term clearance of anogenital warts in those patients in whom imiquimod monotherapy is insufficient...
Changing paradigms in dermatology: antivirals in dermatologyPeggy Lin
Department of Dermatology, Northwestern University School of Medicine, Chicago, Illinois, USA
Clin Dermatol 21:426-46. 2003..Most of these antiviral drugs are virastatic and not viracidal. Vaccines and public health measures are much more effective and cost effective than antiviral drugs and must be promoted accordingly in the defense against viral infections...
Vaccines and immunotherapies for the prevention of infectious diseases having cutaneous manifestationsJashin J Wu
Center for Clinical Studies, Houston, Texas, USA
J Am Acad Dermatol 50:495-528; quiz 529-32. 2004..With this progress, it is hoped that effective vaccines soon will be developed for many more infectious diseases with cutaneous manifestations...
Selected sexually transmitted diseases and their relationship to HIVJashin J Wu
Department of Dermatology, University of California College of Medicine Irvine, Irvine, California, USA
Clin Dermatol 22:499-508. 2004....
Advances in antiviral therapyJashin J Wu
Department of Dermatology, University of California at Irvine, 92697-2400, USA
Dermatol Clin 23:313-22. 2005..There are multiple vaccines available for certain viral diseases and others in development for HSV-2 and HPV...
Rickettsial infections around the world, part 1: pathophysiology and the spotted fever groupJashin J Wu
Department of Dermatology, University of California, Irvine, California, USA
J Cutan Med Surg 9:54-62. 2005..Participants should also be familiar with the pathophysiology of the rickettsial diseases...
Safety and tolerability of a high-potency zoster vaccine in adults >/= 50 or years of ageStephen K Tyring
University of Texas Health Science Center, Houston, TX, USA
Vaccine 25:1877-83. 2007..This study of people >/= 50 or years of age compared the safety and tolerability of two zoster vaccine potencies...
Treatment and prevention of rickettsial and ehrlichial infectionsJennifer L Maender
Department of Medicine, Christus St. Joseph Hospital, Houston, TX, USA
Dermatol Ther 17:499-504. 2004..Human ehrlichiosis can present as monocytic ehrlichiosis or granulocytic anaplasmosis. Prevention is by avoidance of the responsible vectors. Therapy is usually with doxycycline, but chloramphenicol can also be used...
Topical resiquimod 0.01% gel decreases herpes simplex virus type 2 genital shedding: a randomized, controlled trialKaren E Mark
Department of Medicine, University of Washington, Seattle, WA 98104, USA
J Infect Dis 195:1324-31. 2007..In animal models, induction of Th1-specific responses modifies experimental herpes simplex virus (HSV) infection...
Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trialAlan Menter
Division of Dermatology, Baylor Research Institute, University of Texas Southwestern Medical School, 3900 Junius St, 125, Dallas, TX 75246 1613, USA
J Am Acad Dermatol 58:106-15. 2008..Adalimumab is a fully human monoclonal antibody that binds tumor necrosis factor, a key proinflammatory cytokine involved in the pathogenesis of psoriasis...
Once-daily valacyclovir to reduce the risk of transmission of genital herpesLawrence Corey
Department of Medicine, University of Washington, Seattle, USA
N Engl J Med 350:11-20. 2004..Nucleoside analogues against herpes simplex virus (HSV) have been shown to suppress shedding of HSV type 2 (HSV-2) on genital mucosal surfaces and may prevent sexual transmission of HSV...
A novel targeted T-cell modulator, efalizumab, for plaque psoriasisMark Lebwohl
Mt. Sinai School of Medicine, New York 10029-6574, USA
N Engl J Med 349:2004-13. 2003..CONCLUSIONS: Efalizumab therapy resulted in significant improvements in plaque psoriasis in subjects with moderate-to-severe disease. Extending treatment from 12 to 24 weeks resulted in both maintenance and improvement of responses...
Recent clinical experience with famciclovir--a "third generation" nucleoside prodrugArun Chakrabarty
Solano Research, Davis, Calif, USA
Antivir Chem Chemother 15:251-3. 2004..This short review points to recent experience with famciclovir in the management of HSV and varicella-zoster virus...
Oral famciclovir for the suppression of recurrent genital herpes: the combined data from two randomized controlled trialsStephen K Tyring
University of Texas Medical Branch, Galveston, USA
J Cutan Med Surg 7:449-54. 2003..Genital herpes is a very common sexually transmitted disease. Safe and effective therapies are needed for patients with frequent recurrences...
Recommendations for the management of herpes zosterRobert H Dworkin
Department of Anesthesiology, University of Rochester School of Medicine and Dentistry, Rochester, NY, 14642, USA
Clin Infect Dis 44:S1-26. 2007..Specific recommendations for the use of these medications are provided. In addition, suggestions are made for treatments that, when used in combination with antiviral therapy, may further reduce pain and other complications of HZ...
Etanercept: an overview of its role in the treatment of psoriasisMalini Patel Galindo
Center for Clinical Studies, 6655 Travis 120, Houston, TX 77030, USA
Expert Opin Drug Metab Toxicol 4:305-10. 2008..Psoriasis is a chronic and disabling disease affecting patients' quality of life...
Effect of imiquimod in anogenital warts from HIV-positive menSilvia Herrera
GRID, Dermatology Section, Department of Internal Medicine, University of Antioquia, Medellin, Colombia
J Clin Virol 39:210-4. 2007..HIV-positive patients have unpredictable local immune responses even with severe systemic immunosuppression and data reported to date is insufficient to predict the effect of imiquimod in HIV-positive patients...
Herpes simplex viruses 1 and 2Kimberly A Yeung-Yue
Departments of Dermatology, Microbiology/Immunology, and Internal Medicine, University of Texas Medical Branch-Galveston, Galveston, TX 77555, USA
Dermatol Clin 20:249-66. 2002..Newer treatments, such as resiquimod, actually may alter the course of HSV infection, reducing the severity and frequency of recurrences. Vaccines are being explored as preventive and therapeutic measures against HSV...
Incidence of infection during efalizumab therapy for psoriasis: analysis of the clinical trial experienceRichard G B Langley
Dalhousie University, Halifax, Nova Scotia, Canada
Clin Ther 27:1317-28. 2005..Efalizumab is a biologic therapy targeted to inhibit T cells. Its efficacy has been shown in clinical trials encompassing >3500 patients with psoriasis...
Valacyclovir for herpes simplex virus infection: long-term safety and sustained efficacy after 20 years' experience with acyclovirStephen K Tyring
University of Texas Medical Branch, Galveston, Texas 77555, USA
J Infect Dis 186:S40-6. 2002..Extensive sensitivity monitoring of HSV isolates confirmed a very low rate of acyclovir resistance among immunocompetent subjects (<0.5%). The incidence of resistance among immunocompromised patients remains low at about 5%...
Emerging therapies for herpes viral infections (types 1 - 8)Arun Chakrabarty
Solano Clinical Research, Davis, California, USA
Expert Opin Emerg Drugs 9:237-56. 2004..The new helicase primase inhibitors, which are the first non-nucleoside antiviral compounds, are being investigated for treatment of HSV disease, including infections resistant to existing therapy...
Ustekinumab for chronic plaque psoriasisBrenda L Bartlett
Center for Clinical Studies and Department of Dermatology, University of Texas Health Science Center, Houston, TX 77030, USA
Lancet 371:1639-40. 2008
Family history as a risk factor for herpes zoster: a case-control studyLindsey D Hicks
University of Texas Medical School at Houston, USA
Arch Dermatol 144:603-8. 2008..To assess risk factors for herpes zoster beyond age and immunosuppression, especially the association with a family history of herpes zoster, since a preventative herpes zoster and postherpetic neuralgia vaccine is now available...
A randomized controlled trial of a replication defective (gH deletion) herpes simplex virus vaccine for the treatment of recurrent genital herpes among immunocompetent subjectsGuy de Bruyn
Program in Infectious Diseases, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
Vaccine 24:914-20. 2006..4%, respectively). CONCLUSION: This replication incompetent HSV-2 vaccine lacking the glycoprotein H gene was safe but had no clinical or virologic benefit in the amelioration of genital HSV-2 disease among immunocompetent men and women...
Viral and nonviral uses of imiquimod: a reviewAditya K Gupta
Division of Dermatology, Department of Medicine, Sunnybrook and Women s College Health Science Center, University of Toronto, Toronto, Ontario, Canada
J Cutan Med Surg 8:338-52. 2004..This drug has been recently approved for the treatment of actinic keratoses and superficial basal cell carcinoma. There is a growing body of evidence for its effectiveness in treating a variety of other skin conditions...
Demographic, behavioral, and knowledge factors associated with herpes simplex virus type 2 infection among men whose current female partner has genital herpesRashida K Rana
Worldwide Epidemiology, GlaxoSmithKline Research and Development, Greenford, U.K
Sex Transm Dis 32:308-13. 2005..09), and lower knowledge of GH (aOR, 1.14; CI, 1.05-1.23). CONCLUSION: Potentially modifiable risk factors for HSV-2 infection included engaging in vaginal sex during symptomatic episodes, never using condoms, and lower knowledge of GH...
Postherpetic poliosisJashin J Wu
Arch Dermatol 142:250-1. 2006
Safety and immunogenicity of glycoprotein D-adjuvant genital herpes vaccineDavid I Bernstein
Cincinnati Children s Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio, USA
Clin Infect Dis 40:1271-81. 2005....
A unique pattern of hyperhidrosis and herpes zosterJashin J Wu
Arch Dermatol 142:1069. 2006
Molluscum contagiosum: the importance of early diagnosis and treatmentStephen K Tyring
UTMB Center for Clinical Studies, University of Texas Medical Branch, 301 University Boulevard, Route 1070, Galveston, TX 77555, USA
Am J Obstet Gynecol 189:S12-6. 2003..This review summarizes the clinical diagnosis of molluscum contagiosum and provides a critical assessment of several current and emerging treatment options...
Varicella-zoster virus in the saliva of patients with herpes zosterSatish K Mehta
Enterprise Advisory Services, Inc, USA
J Infect Dis 197:654-7. 2008..Analysis of human saliva has potential usefulness in the diagnosis of neurological disease produced by VZV without rash...
Research Grants
- Genetic Resistance to Oncogenic Human PapillomavirusesStephen Tyring; Fiscal Year: 2004..Thus, this study is an important step in the development of an HPV vaccine to prevent infection. ..
